Company news

Sonoma Pharmaceuticals, Inc. news in 2024

Sonoma Pharmaceuticals, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices

December 4, 2024

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States

November 20, 2024

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn-based Wound Care Hydrogel

November 12, 2024

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel

November 10, 2024

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results

November 6, 2024

Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf

October 30, 2024

Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada

October 23, 2024

Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada

October 21, 2024

Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

September 18, 2024

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution

September 16, 2024

Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line

September 10, 2024

Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock

August 27, 2024

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff

August 25, 2024

Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States

August 20, 2024

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results

August 7, 2024

Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine

July 8, 2024

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results

June 16, 2024

Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores

May 8, 2024

Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States

April 8, 2024

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results

February 7, 2024

Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use

January 22, 2024

Decks in 2024